Cardinal Health, Inc. (CAH) Earnings Call Analysis

NYSE · Healthcare · Medical Distribution

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Cardinal Health (CAH) Q4 2026: 40% Non-GAAP EPS Growth Reflects Broad-Based Segment Strength and Strategic Momentum
August 11, 2026
24
Cardinal Health (CAH) Q2 2026: Specialty Revenue Surges Past $50B Mark, Lifting Outlook
June 15, 2026
23
Cardinal Health (CAH) Q3 2026: Specialty Revenue Surges 20%, Fueling Upgraded Guidance
April 30, 2026
22
Cardinal Health (CAH) Q1 2026: Pharma and Specialty Profit Jumps 26% as Solaris Acquisition Accelerates Scale
October 30, 2025
22
Cardinal Health (CAH) Q4 2025: Specialty Alliance Adds $1.5B Revenue, Fueling Double-Digit EPS Guidance Raise
August 12, 2025
25
Cardinal Health (CAH) Q3 2025: Segment Profit Up 21% as Pharma, Specialty, and Growth Businesses Accelerate
July 04, 2025
Cardinal Health (CAH) Q1 2025: Pharma Segment Profit Surges 16% as Broad Demand Offsets Transition Headwinds
November 01, 2024
Cardinal Health (CAH) Q4 2024: $10B New Revenue Pipeline Offsets $40B Contract Loss
August 14, 2024
Cardinal Health (CAH) Q3 2024: GMPD Profit Swings $66M, Accelerating Turnaround Trajectory
May 02, 2024
Cardinal Health (CAH) Q2 2024: Pharma Profit Up 12% as Specialty Networks Acquisition Signals Strategic Shift
February 01, 2024

Browse all companies